These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11336404)

  • 1. Carrier screening for Gaucher disease in couples of mixed ethnicity.
    Wallerstein R; Starkman A; Jansen V
    Genet Test; 2001; 5(1):61-4. PubMed ID: 11336404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
    Kronn D; Jansen V; Ostrer H
    Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier screening for Gaucher disease: lessons for low-penetrance, treatable diseases.
    Zuckerman S; Lahad A; Shmueli A; Zimran A; Peleg L; Orr-Urtreger A; Levy-Lahad E; Sagi M
    JAMA; 2007 Sep; 298(11):1281-90. PubMed ID: 17878420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal genetic carrier testing using triple disease screening.
    Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
    JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
    Sutton VR
    Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High frequency of the Gaucher disease mutation at nucleotide 1226 among Ashkenazi Jews.
    Zimran A; Gelbart T; Westwood B; Grabowski GA; Beutler E
    Am J Hum Genet; 1991 Oct; 49(4):855-9. PubMed ID: 1897529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of glucocerebrosidase mutations in the Israeli Ashkenazi Jewish population.
    Horowitz M; Pasmanik-Chor M; Borochowitz Z; Falik-Zaccai T; Heldmann K; Carmi R; Parvari R; Beit-Or H; Goldman B; Peleg L; Levy-Lahad E; Renbaum P; Legum S; Shomrat R; Yeger H; Benbenisti D; Navon R; Dror V; Shohat M; Magal N; Navot N; Eyal N
    Hum Mutat; 1998; 12(4):240-4. PubMed ID: 9744474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2 Gaucher disease with hydrops fetalis in an Ashkenazi Jewish family resulting from a novel recombinant allele and a rare splice junction mutation in the glucocerebrosidase locus.
    Reissner K; Tayebi N; Stubblefield BK; Koprivica V; Blitzer M; Holleran W; Cowan T; Almashanu S; Maddalena A; Karson EM; Sidransky E
    Mol Genet Metab; 1998 Apr; 63(4):281-8. PubMed ID: 9635296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prenatal panel screening considerations for non-neuronopathic Gaucher disease in the Ashkenazi-Jewish population.
    Kannai R; Chertok IR
    Isr Med Assoc J; 2006 May; 8(5):347-50. PubMed ID: 16805236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proof-of-principle rapid noninvasive prenatal diagnosis of autosomal recessive founder mutations.
    Zeevi DA; Altarescu G; Weinberg-Shukron A; Zahdeh F; Dinur T; Chicco G; Herskovitz Y; Renbaum P; Elstein D; Levy-Lahad E; Rolfs A; Zimran A
    J Clin Invest; 2015 Oct; 125(10):3757-65. PubMed ID: 26426075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gaucher disease: gene frequencies and genotype/phenotype correlations.
    Grabowski GA
    Genet Test; 1997; 1(1):5-12. PubMed ID: 10464619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type 1 Gaucher disease: significant disease manifestations in "asymptomatic" homozygotes.
    Balwani M; Fuerstman L; Kornreich R; Edelmann L; Desnick RJ
    Arch Intern Med; 2010 Sep; 170(16):1463-9. PubMed ID: 20837833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal healthcare providers' Gaucher disease carrier screening practices.
    Falcone D; Wood EM; Mennuti M; Xie SX; Van Deerlin VM
    Genet Med; 2012 Oct; 14(10):844-51. PubMed ID: 22653536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update of Gaucher mutations distribution in the Ashkenazi Jewish population: prevalence and country of origin of the mutation R496H.
    Bronstein S; Karpati M; Peleg L
    Isr Med Assoc J; 2014 Nov; 16(11):683-5. PubMed ID: 25558695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carrier testing for Ashkenazi Jewish disorders in the prenatal setting: navigating the genetic maze.
    Ferreira JC; Schreiber-Agus N; Carter SM; Klugman S; Gregg AR; Gross SJ
    Am J Obstet Gynecol; 2014 Sep; 211(3):197-204. PubMed ID: 24508465
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of couples identified through screening as carriers of Gaucher disease type 1.
    Zuckerman S; Lahad A; Zimran A; Levy-Lahad E; Sagi M
    Clin Genet; 2008 Dec; 74(6):566-70. PubMed ID: 18651845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA-based carrier screening in the Ashkenazi Jewish population.
    Zhang B; Dearing L; Amos J
    Expert Rev Mol Diagn; 2004 May; 4(3):377-92. PubMed ID: 15137904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of chromosome testing in couples with recurrent miscarriage to prevent handicapped offspring.
    van Leeuwen M; Vansenne F; Korevaar JC; van der Veen F; Goddijn M; Mol BW
    Hum Reprod; 2013 Jul; 28(7):1737-42. PubMed ID: 23613277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 1226G (N370S) Gaucher mutation among patients with Legg-Calve-Perthes disease.
    Kenet G; Hayek S; Mor M; Lubetsky A; Miller L; Rosenberg N; Mosheiff R; Itzchaki M; Elstein D; Wientroub S; Zimran A
    Blood Cells Mol Dis; 2003; 31(1):72-4. PubMed ID: 12850487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliable co-segregation analysis for prenatal diagnosis and heterozygote detection in Gaucher disease.
    Cormand B; Montfort M; Chabás A; Grinberg D; Vilageliu LL
    Prenat Diagn; 1998 Mar; 18(3):207-12. PubMed ID: 9556036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.